NCT03574142View on ClinicalTrials.gov

A Ph 1 Study of Epanova® in Healthy Chineses

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 4, 2018

Primary Completion Date

June 27, 2018

Study Completion Date

June 27, 2018

Conditions

Healthy Subjects

Interventions

DRUG

Epanova

A single dose of Epanova 4 g will be administered as 4 capsules (each containing 1 g of Epanova) followed by a 72-hour washout period in Chinese healthy subjects. Subsequently, multiple doses of Epanova 4 g will be administered once daily for 14 consecutive days.

Trial Locations (1)

100029

Research Site, Beijing